| Literature DB >> 27960350 |
Eric M Gale1, Chloe M Jones1, Ian Ramsay1, Christian T Farrar1, Peter Caravan1.
Abstract
We introduce a new biochemically responsive Mn-based MRI contrast agent that provides a 9-fold change in relaxivity via switching between the Mn3+ and Mn2+ oxidation states. Interchange between oxidation states is promoted by a "Janus" ligand that isomerizes between binding modes that favor Mn3+ or Mn2+. It is the only ligand that supports stable complexes of Mn3+ and Mn2+ in biological milieu. Rapid interconversion between oxidation states is mediated by peroxidase activity (oxidation) and l-cysteine (reduction). This Janus system provides a new paradigm for the design of biochemically responsive MRI contrast agents.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27960350 PMCID: PMC5328420 DOI: 10.1021/jacs.6b10898
Source DB: PubMed Journal: J Am Chem Soc ISSN: 0002-7863 Impact factor: 15.419